Faricimab Injection [Vabysmo] clinical trials

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

This study is looking at a new treatment called faricimab (Vabysmo) for an eye condition called polypoidal choroidal vasculopathy (PCV) in white patients. We want to see how well it works, if it's safe, and how long the effects last, aiming to improve eyesight and reduce the need for frequent eye injections.